VRK2 inhibition synergizes with PD-1 blockade to improve T cell responses
Author:
Funder
Cancer Research Institute
National Institutes of Health
Publisher
Elsevier BV
Subject
Immunology,Immunology and Allergy
Reference30 articles.
1. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion;Dong;Nat. Med.,1999
2. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation;Freeman;J. Exp. Med.,2000
3. PD-L2 is a second ligand for PD-1 and inhibits T cell activation;Latchman;Nat. Immunol.,2001
4. B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells;Tseng;J. Exp. Med.,2001
5. Affinity purification mass spectrometry analysis of PD-1 uncovers SAP as a new checkpoint inhibitor;Peled;Proc. Natl. Acad. Sci. U.S.A.,2018
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Mitochondrial DNA-targeted therapy: A novel approach to combat cancer;Cell Insight;2023-08
2. Reduced Vrk2 expression is associated with higher risk of depression in humans and mediates depressive-like behaviors in mice;BMC Medicine;2023-07-14
3. Role of protein phosphorylation in cell signaling, disease, and the intervention therapy;MedComm;2022-11-03
4. Combination Approaches to Target PD-1 Signaling in Cancer;Frontiers in Immunology;2022-07-14
5. Data on the identification of VRK2 as a mediator of PD-1 function;Data in Brief;2021-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3